Dr. Karrie Hendrickson published an article in 2009 analyzing patterns of hospital resource utilization of children with leukemia and CNS tumors. Dr. Hendrickson used quantitative research as her means of analysis. In her article, Dr. Hendrickson specifies the population as children ages 0 to 19 years diagnosed with cancer at a large north-eastern hospital between fiscal years 2000 and 2004. Specifically, she focused on children diagnosed with leukemia and CNS tumors, as these account for about 50% of deaths of children with cancer each year. The article clearly identifies the variables as well as the relationship between the variables such as relationship between PICU admissions and survival rates of patients.
Of the billions of dollars spent each year on cancer treatments and research less than a third is contributed to researching pediatric cancer. Given the media focus on adult cancers, research for pediatric cancer is underfunded. In order to maintain the increasing survival rate of the children undergoing pediatric cancer and support those who have survived the disease, better funding is quintessential to develop and further promote research. Government funding has proven to be essential and effective in the fight against cancer. On December 23, 1971 President Nixon signed the National Cancer Act, which promised to finance the quest for the cure.
Out of those diagnosed, white children seemed more often affected than children of other races and males were slightly more affected than females (Kanwar, 2013). The frequency of childhood ALL cases crest at ages 2 to 5 and then decreases as they grow older (Kanwar, 2013). Unfortunately, there are no identifiable causes associated with this cancer. However, according to the Mayo Clinic Staff (2012), factors that can increase the chance of getting ALL include previous cancer treatment, exposure to radiation, existing genetic disorders, and having a sibling with ALL. On the bright side of this horrible news, the overall survival rate for this type of cancer is now over 85 percent (American Cancer Society, 2013)95.
Introduction Keeping patients safe is essential in today’s health care system, but patient safety events that violate that safety are increasing each year. It was only recently, that the focus on patient safety was reinforced by a report prepared by Institute of medicine (IOM) entitled ” To err is human, building a safer health system”(Wakefield & Iliffe,2002).This report found that approx-imately 44,000 to 98,000 deaths occur each year due to medical errors and that the majority was preventable. Deaths due to medical errors exceed deaths due to many other causes such as like HIV infections, breast cancer and even traffic accidents (Wakefield & Iliffe, 2002). After this IOM reports, President Clinton established quality interagency coordination task force with the help of government agencies. These government agencies are responsible for making health pol-icies regarding patient safety to which every HCO must follow (Schulman & Kim, 2000).
Infant and Pediatric Mortality Rates Mortality rates of pediatric and neonatal patients have improved over the past few decades though, some countries still lack the improvement that has been witness elsewhere. The issue lies within the simple precautions that can be taken to prevent multiple deaths of infants and children. Nurses are also effect by the deaths of their patients. Future implications need to be set fourth to not only benefit the patients but the nurses as well. The Now In 2013 the mortality average for children aged one to four in the United States was about 25.5 out of every 100,000 of the population.
Usually an immediate surgery is needed after birth to minimize the risk of death. Afterwards, CCHD babies are then monitored by cardiologists for a couple of years to make sure they are stable. CCHD babies show obvious signs and symptoms that help physicians come up with a diagnosis and treatment, but other conditions do not show any signs unless further tests are done, such as Wolff-Parkinson-White (WPW) Syndrome. WPW syndrome... ... middle of paper ... ...at WPW syndrome “occurs randomly in the general population, occurring in about 1 to 3 per 1,000 persons,” (Cleveland Clinic, 2014) and is more prevalent in men than women. WPW syndrome can also be inherited if parents have accessory pathway genes.
This source was very helpful for me to use in my research. It shapes my argument because it’s got info about both sides so I can use them. This hasn’t changed what I think about my topic.
This paper investigates the challenges that a family will experience from the first diagnoses through palliative care. It examines research and statistic about childhood cancer from organization as the American Society of Clinical Oncology (ASCO), the National Cancer Institute's (NCI), Children’s Cancer Research Fund (CCRF), and other cancer research organization. Although there are 12 major types of cancers that affect children, the main focus in this paper will be acute lymphocytic leukemia (ALL). It will also include an interview, the personal experiences of a family, real life emotions, and the effect on the parents and sibling of the (Ashtyn) child presently facing acute lymphocytic leukemia (ALL). Life is no longer what formerly was known as being normal.
So if childhood cancer would get your awareness and funding, together we can help children fight and survive cancer to live a long and healthy life after cancer. Childhood cancers get an unacceptable amount of government cancer research funding, less than four percent. Childhood cancer isn’t rare. Every three minutes, somewhere a child will die from this horrible disease. The fact that the government spends so little on these suffering children is unacceptable.
For many years now, endoscopic surveillance of all patients with BE seemed to make sense. Previous studies showed high risk of esophageal cancer in non-dysplastic BE (~2%/ year) and, based on small retrospective surgical case series, there appeared to be some merit to endless continued surveillance. However, over the last few years, several important papers were published that have changed our understanding of the natural history of non-dysplastic BE. In 2011, Hvid-Jensen et al reported a low annual incidence of esophageal cancer of 0.12% in a large population based cohort study on 11, 028 Danish patients with BE3. This was much lower than the previously reported rate of 0.5% per year.